Singapore Markets closed

Noble Corporation Plc (NE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
39.47+0.37 (+0.95%)
At close: 04:00PM EDT
39.37 -0.10 (-0.26%)
After hours: 04:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 345.50
52-week low 322.64
50-day moving average 340.49
200-day moving average 334.65

Share statistics

Avg vol (3-month) 32M
Avg vol (10-day) 31.34M
Shares outstanding 5134.68M
Implied shares outstanding 6N/A
Float 8129.61M
% held by insiders 10.88%
% held by institutions 170.82%
Shares short (30 Jan 2023) 44.55M
Short ratio (30 Jan 2023) 42.24
Short % of float (30 Jan 2023) 4N/A
Short % of shares outstanding (30 Jan 2023) 43.39%
Shares short (prior month 29 Dec 2022) 45.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 307 Aug 2016
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 328 Aug 2007

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 16.76%
Operating margin (ttm)7.71%

Management effectiveness

Return on assets (ttm)2.02%
Return on equity (ttm)10.80%

Income statement

Revenue (ttm)939.44M
Revenue per share (ttm)13.70
Quarterly revenue growth (yoy)25.20%
Gross profit (ttm)95.78M
EBITDA 225.17M
Net income avi to common (ttm)157.42M
Diluted EPS (ttm)-20.28
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)422.49M
Total cash per share (mrq)3.23
Total debt (mrq)434.37M
Total debt/equity (mrq)28.05
Current ratio (mrq)2.81
Book value per share (mrq)22.71

Cash flow statement

Operating cash flow (ttm)137.39M
Levered free cash flow (ttm)62.12M